


Healthcare News Roundup: Oncology
HSMN NewsFeed - 8 Dec 2022
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
HSMN NewsFeed - 28 Oct 2022
McLaren Proton Therapy Center - Karmanos Cancer Institute, selects RayStation for proton planning
McLaren Proton Therapy Center - Karmanos Cancer Institute, selects RayStation for proton planning
